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Tioconazole (TCZ), a broad-spectrum antifungal agent, has significant activity against Candida albicans
and other Candida species, and therefore, it is indicated for the topical treatment of superficial mycoses.
The main goal of this work is to report an exhaustive identification and characterization procedure to
improve and facilitate the online quality control and continuous process monitoring of TCZ in bulk
material and loaded in two different dosage forms: ovules and nail lacquer. The methodologies were
based on thermal (differential scanning calorimetry (DSC), melting point, and thermogravimetry (TG)),
spectroscopic (ultraviolet (UV), Raman, near infrared (NIR), infrared spectroscopy coupled to attenuated
total reflectance (FTIR-ATR), and nuclear magnetic resonance (NMR)), microscopic and X-ray diffraction
(XRD). The TCZ bulk powder showed a high crystallinity, as observed by XRD, with a particles size dis-
tribution (3–95 mm) resolved by microscopic measurements. TCZ melting point (82.8 °C) and a de-
gradation peak centered at 297.8 °C were obtained by DSC and DTG, respectively. An unambiguous
structure elucidation of TCZ was obtained by mono- and two- dimensional 1H and 13C NMR spectral data
analysis. The FTIR-ATR, Raman and NIR spectra of both the raw material and the commercial products
were analyzed and their characteristic bands were tabulated. The best methods for TCZ identification in
ovules were DSC, TG, XRD, NIR and Raman, while NIR and FTIR-ATR were the most appropriate tech-
niques to analyze it in the nail lacquer. DSC, TG, DRX, Raman, FTIR-ATR and NIR spectroscopy are effective
techniques to be used in online process analysis, because they do not require sample preparation, and
they are considerably sensitive to analyze complex samples.
& 2018 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
On line quality control and continuous process monitoring have
received increasing attention, mainly to decrease production time,
reduce human errors, prevent product rejections and improve
efficiency. The manufacturing process frequently requires the on-
going physicochemical analysis of the product. In this regard,
pharmaceutical drug characterization and identification can be
performed by several analytical techniques [1–3]. Usually, theon and hosting by Elsevier B.V. Th
niversity.
sario (IQUIR, CONICET-UNR),
Calvo),preferred approach is the use of combined techniques to achieve a
better overall understanding of the properties of the active phar-
maceutical ingredient (API). In the last decades, spectroscopic
analyses have been employed to identify APIs even in biological
materials [4] and complex matrices to rule out adulterations and
fraudulent products [5]. Among spectroscopic analyses, Fourier
transformed infrared spectroscopy coupled to attenuated total
reflectance (FTIR-ATR) [6], near infrared (NIR) [7] and Raman [8]
are the major techniques applied in green analytical chemistry.
These techniques are non-destructive, allow the analysis of liquid,
solid, and semi-solid samples, allow the direct measurement of
untreated samples, and do not produce hazardous wastes [9]. On
the other hand, nuclear magnetic resonance (NMR) spectroscopy
has evolved into an irreplaceable approach for pharmaceutical
quality assessment, currently playing a critical role in unequivocalis is an open access article under the CC BY-NC-ND license
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(qualitative detection), which enables the understanding of the
underlying mechanisms of the formation of process and/or
degradation impurities [10]. NMR can provide qualitative in-
formation, without the need for standards of the unknown com-
pounds [11]. Thermogravimetry (TG) and differential scanning
calorimetry (DSC) are useful techniques that have been success-
fully applied in the pharmaceutical industry to reveal important
information regarding the physicochemical properties of drug and
excipient molecules such as polymorphism, stability, purity, and
formulation compatibility among others [12–15].
Tioconazole (TCZ), 1-[2-[(2-chloro-3-thienyl)methoxyl]-2-(2,4-
dichlorophenyl)ethyl]-1H-imidazole, is a broad-spectrum anti-
fungal agent against dermatophytes, yeasts of the genus Candida,
as well as some Chlamydia, Trichomonads and some gram-positive
bacteria [16].
TCZ has greater fungicidal activity than clotrimazole, econazole,
ketoconazole, and miconazole against Candida albicans and other
Candida species; therefore, it is used for the topical treatment of
superficial mycoses, especially those resulting from fungal infections
of the skin and nails [17], and for the treatment of vaginal candidiasis
[18]. TCZ monograph is included in Argentinian Pharmacopoeia [19],
United Stated Pharmacopoeia (USP) [20] and British Pharmacopoeia
(BP) [21], where the bulk drug identification is by infrared spectro-
scopy (IR), thin-layer chromatography and HPLC. With the exception
of IR identification tests for bulk drug, these methodologies require
skilled manpower and demand the use of significant amounts of
organic solvents. Besides, they are time-consuming, poorly eco-
friendly, and measurements cannot be carried out online.
Therefore, this study provides a complete insight into the
physicochemical identification and structural characterization of
TCZ both as bulk material and in pharmaceutical dosage forms by
means of different analytical techniques, some of which are eco-
friendly and also could be carried out on-line.2. Material and methods
2.1. Chemical and reagents
TCZ raw material (purity 100.74%) of pharmaceutical grade (BP
2002) was acquired in Saporiti (Buenos Aires, Argentina). During
the experiments, the drug was kept in a desiccator. Double-distilled
water was used for the preparation of aqueous solutions. All other
chemicals were of analytical grade. Pharmaceutical dosage forms:
(1) TCZ ovule (Honguil – Raymos Laboratories, Argentina) contain-
ing TCZ 14.3% (w/w) and excipients (liquid vaseline 21.4% (w/w) and
solid vaseline 64.3% (w/w)), and (2) TCZ nail lacquer (Trosyd–Pfizer
Laboratories Argentina), containing TCZ 28.0% (w/w) and excipients
(undecylenic acid 22.0% (w/w) and ethyl acetate 50.0% (w/w)), were
acquired at a local drugstore.
2.2. Methods
2.2.1. Thermal analysis
Calorimetric determinations were performed in a Linseis
PT1000 differential scanning calorimeter (Linseis Inc., New Jersey,
USA), operating under a constant nitrogen flow of 8 L/h.
The samples (2mg API and 5–6mg commercial products) were
placed in closed aluminum pans perforated with a pin-hole to
equilibrate pressure from potential expansion of evolved gases or
residual solvents, heated at a rate of 10 °C/min between 40 and
145 °C and cooled at a rate of 5 °C/min between 145 and 55 °C. An
empty pan was used as a reference.
The melting point behavior of TCZ was also examined with an
Electrothermal, model 9100 digital melting point instrument(Bibby Scientific Ltd., Staffordshire, UK). The samples were heated
at 10 °C/min up to 10 °C below the temperature of interest; then,
the heating rate was changed to 1 °C/min.
Thermogravimetric tests were carried out with a thermal
analyzer (Model TGA Q500, Hüllhorst, Germany). Samples (around
8mg) were heated at a constant rate of 10 °C/min from room
temperature up to 600 °C under a nitrogen flow of 30mL/min in
order to avoid the thermo oxidative reactions.
2.2.2. Fourier transformed infrared spectroscopy
Infrared spectra were acquired in a Shimadzu Prestige 21
spectrometer (Shimadzu Corp., Kyoto, Japan) over a wave number
range of 4000–600 cm1. ATR experiments were carried out with
a diamond-based ATR accessory (GladiATR, Pike Technologies,
Madison, USA) fitted with a Pike temperature control unit. An
average of 20 scans was used at a 4 cm1 resolution between 4000
and 600 cm1 in all cases. The temperature (30 °C), the amount of
sample (around 20mg) and the pressure exerted on the sample
during the measurement were standardized. Each sample was
scanned three times to observe good reproducibility and the
scanned measurements were averaged.
2.2.3. Near infrared spectroscopy
The near infrared spectra were measured at room temperature
with a spectrometer NIRS DS2500 FOSS (FOSS, Hillerod, Dina-
marca). Solid sample (700mg) was placed in a circular quartz cell
for solids, while liquid and semisolid samples (1mL) were placed
in a circular quartz cell for liquids. The NIR data were an average of
7 scans in all cases, collected in the spectral range 400–2500 nm.
To achieve a sufficient signal to noise ratio, all samples were
measured by triplicate and averaged.
2.2.4. Raman spectroscopy
The FT-Raman experiments were performed with a hand-held
AHURA TRUSCAN instrument, operated in the range 2875–
230 cm1, at a nominal resolution of 7 cm1. The laser excitation
wavelength was 785 nm, using 2 cm1 linewidth and mono-
chromator spectral range of 781–1014 nm. The samples (1 cm3)
were placed in closed glass vials.
2.2.5. UV-DAD spectroscopy
The spectroscopic determinations in the UV were carried out
with an Agilent 8453 UV–DAD spectrophotometer (Agilent Tech-
nologies, Santa Clara, USA), controlled by the Chemstation v. B04-
02 software, at a 1 nm resolution, between 190 and 1100 nm. The
determinations were performed in a quartz cuvette (10mm optical
path length) against a blank of double-distilled water.
Stock standard solutions of TCZ (200 μg/mL) were prepared in
25mL volumetric flasks, by dissolving accurately weighed
amounts of the drug in acetonitrile. The working solution
(9.5 μg/mL) was prepared by transferring appropriate volumes of
the stock solutions to separate 50mL volumetric flasks and di-
luting with water to their mark.
2.2.6. X-ray diffraction analysis (XRD)
XRD analysis was carried out with a PAN analytical X′Pert PRO
diffractometer (Netherlands) equipped with a monochromatic Cu
Kα radiation source (λ ¼ 1.5406 Å) operating at a voltage of 40 kV
and current of 40mA at a scanning rate of 0.02°/s. The scanning
region of the samples (solid samples: 500mg and liquid or semi-
solid samples: 1mL) was in a 2θ range between 5° and 40°.
2.2.7. Morphology analysis and size determination by scanning
electron microscopy
The particle size and morphology of raw TCZ (around 10mg)
were investigated by scanning electron microscopy (SEM, AMR
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aluminum sample support using conductive, double-sided ad-
hesive tape. Samples were coated with a fine gold layer for 15min
at 70–80 mTorr in order to make them conductive before obtaining
the SEM micrographs. All samples were examined using an ac-
celerating voltage of 20 kV and magnifications of 500 , 1000
and 5000 . SEM images were analyzed using the Image-Pro Plus
(IPP) software v. 6.0 to determine an indirect estimation of the
particle size. The particle size was determined by an indirect es-
timation using the Feret's diameter which is the distance between
the two furthest points of the shape measured in a given direction.
About 200 particles Feret's diameters were considered in each
particle size distribution calculation [22,23].
2.2.8. Nuclear magnetic resonance (NMR)
The 1H and 13C NMR spectra were acquired in DMSO-d6 in a
Bruker Avance spectrometer (300.13 and 75.48MHz for 1H and
13C, respectively) with tetramethylsilane (TMS) as an internal
standard (Bruker BioSpin GmbH, Karlsruhe, Germany). The 1H and
13C NMR spectra of samples (around 10mg TCZ) were exported in
txt format. NMR signals are abbreviated as follows: s ¼ singlet;
d ¼ doublet; dd ¼ doublet of doublets; t ¼ triplet and m ¼ mul-
tiplet. The chemical shifts (δ) are reported in ppm downfield from
TMS; coupling constants (J). Special 1D (DEPT 135) and 2D (COSY,
HMBC and HSQC) NMR experiments were also acquired, to better
ascertain H─H and C─H connectivity and proximity.3. Results and discussion
3.1. Characterization of bulk drug
3.1.1. Thermal analysis
In the DSC analysis, TCZ exhibited a single endothermic peak
(Fig. 1A), without shoulders at 82.8 °C, with an onset temperature of
77.6 °C, associated with the melting process [24]. These results were
in agreement with the data recorded with the melting point appa-
ratus (80.2–81.1 °C), and also in accordance with the literature (82 °C)
[25]. The calculated melting heat was 71.17 J/g. Additionally, no re-
crystallization peak was observed in the corresponding cooling curve.
Regarding the thermogravimetric analysis, the entire weight
loss of TCZ was observed in one single stage in the temperatureFig. 1. Thermograms of TCZ. (Arange of 180–307 °C. Derivative of the residual mass as a function
of temperature (DTG, Fig. 1B) displayed a degradation peak cen-
tered at around 297.8 °C.
3.1.2. Spectroscopy data
The FTIR-ATR spectrum of TCZ (Fig. 2A) was in agreement with
reference of the standard TCZ (KBr disks) of BP 2010 [21].
The informative spectral ranges were examined, the char-
acteristic peaks corresponding to ν(C═N) of the imidazol group
1562.3 cm1, δ(C─H) 1464.0 cm1, ν(CQC) 1433.1 cm1, ν(C─N)
1278.8 cm1, ν(C─O─C) 1118.7 cm1, ν(C─S) 733.0 cm1 and
ν(C─Cl) 626.9 cm1 were identified [26,27].
Fig. 2B shows the following bands at 1112, 1394.5, 1458.5, 1634,
1717.5, 1760.5, 1793.5, 1816.5, 2152.5, 2220, 2239, 2275, 2304.5,
2339.5, 2388.5, 2417.5 and 2489.5 nm in the NIR spectrum.
The absorption in the near infrared corresponds to the overtones
and bands of the combination of the fundamental vibrations ob-
served in the middle infrared. These bands are less likely than the
fundamental transitions, which causes the absorption in the NIR
region to be of less intensity. Organic compounds have many vi-
brational modes that cause the NIR spectrum to be complex and
formed by broad and ill-defined bands [28]. The intensity of ab-
sorption in the NIR region depends on the anharmonicity of the
bond; the more anharmonic, the greater probability for overtones
and combination bands. For this reason, the bonds C–H, N–H, and
O–H are very anharmonic due to the differences in the atomic
weight between the two atoms, thus being very absorbent in the
NIR region. The bands of groups CQO, C–C, C–F and C–Cl, in gen-
eral, have lower intensity or do not appear in the NIR region [29].
The combination bands of the CH and CH2 groups can be ob-
served between 2200 and 2500 nm [30], while the combination
bands of the NH bonds appear in the region of 2150–2200 nm [31].
The first overtone of the CH and CH2 stretching vibrations was
found in the 1700–1800 nm region [32]. The band at 1634 nm
corresponds to the first overtone of the AR-CH stretching vibra-
tions, while the bands caused by the association of the first over-
tone of the CH and CH2 stretching vibrations and its combination
bands can be observed at 1350–1500 nm region. Finally, the band
at 1112 nm corresponds to the second overtone of the AR-CH
stretching vibrations [33,34].
Fig. 2C shows the Raman spectrum with a vibrational band at
1420.9 cm1 that is assigned to the imidazole ring, whereas the) DSC and (B) TG and DTG.
Fig. 2. (A) FTIR-ATR, (B) NIR and (C) Raman spectra of TCZ bulk drug.
Fig. 3. Crystanillity, particle size and morphology of TCZ. (A) XRD powder pattern.
SEM micrographs at (B) 200 , (C) 1000 , and (D) 5000 magnifications.
Fig. 4. NMR 13C (16 peaks) and DEPT 135 spectrum (11 peaks).
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those of γ (C4ClH2S) chlorothiophene ring. The bands at 398.3,
450.4, 666.2, 856.8, 1207.8, 1279.5, and 1347.7 cm1 refer to the δ
(C6H3Cl2) dichlorophenyl ring [35].
A stock solution of 9.5 μg/mL of TCZ was prepared in water and
scanned by UV spectrophotometer to determine TCZ λmax (Fig.
S1). The molecule presented two λmax, an intense band at 199 nm
and a lower intensity band at 225 nm [27]. Such spectrum is si-
milar to those observed in other imidazoles, such as sulconazole
and econazole nitrate [36].
3.1.3. Crystanillity, particle size and morphology
The crystalline character of the drug was confirmed through an
XRD analysis (Fig. 3). The TCZ raw material showed an intense
peak at 22.33°, which is in agreement with that in a previous re-
port [24]. In addition to the diffraction peaks indicated in Fig. 3A,
peaks at 2θ around 8.71, 10.39, 13.49, 13.83, 24.61, 25.33, 26.27,
28.99, 29.39, 32.17, 32.77, and 38.59° were also observed.As it can be observed in Figs. 3B-D, TCZ crystals appear as a
mixture of smooth-surfaced irregular blocks of different shapes
and sizes. As mentioned, particle size was determined employing
the IPP software v. 6.0 which calculates the Feret's diameter from
the images. Feret's diameter computed from binary images is used
for estimation of length and width of dust particles [23]. The
smooth surface is clearly observed when magnifications of
1000 and 5000 were applied. Also, a few smaller particles
(3–12 mm) appearing over crystals (20–48 mm) were observed. At
smaller magnification (200 ), TCZ blocks (55–95 mm) can be
distinguished.
3.1.4. NMR data analysis
Only one previous work has been carried out on the TCZ
structural elucidation using NMR 13C, 1H, DEPT and HMBC [26].
However, some assignments require a deeper analysis, adding
other NMR techniques such as HSQC and COSY, to confirm the
correspondence between spectra and structure [11].
NMR 13C spectrum showed 16 peaks corresponding to the 16
carbons of the molecule (Fig. 4). The DEPT 135 experiment enabled
the classification of the carbon types present [37]. Eleven peaks
were observed (2 with negative intensity corresponding to
two carbons CH2, and 9 with positive intensity due to CH carbons,
only one of which has hybridation sp3 at 76.39 ppm), and the
Fig. 5. 1H NMR spectra of TCZ.
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The 1H NMR spectra of TCZ (Fig. 5) revealed four signals of
hydrogen sp3, one multiplet in the region 4.24–4.19 ppm, which
was assigned to Hd (2H), and two as doublets at δ 4.26 and δ 4.33
ppm (1H each). The last one, which was observed at 4.96 ppm as
doublet of doublets, was assigned to He (1H, J ¼ 4.1/ 6.7 Hz).
The signals corresponding to the imidazole group were two
triplets at δ 6.83 ppm and δ 7.00 ppm (1H each, J ¼ 1.1 Hz), which
were attributed to Hb and Hc, respectively, and a signal resonating
at 7.47–7.43 ppm, assigned to Ha.Fig. 6. 2D HSQC spectra. (A) Pure shift HSQC spectrum in the region of 48–79/5.1–4.1 ppTwo additional doublets at δ 6.84 and δ 7.39 were attributed to
Hj and Hk (1H each, J ¼ 5.7 Hz), respectively. However, it can be
observed that the Hj signal partially overlaps with Hb.
A couple of doublets at δ 7.36 (J ¼ 8.4 Hz) and δ 7.64 (J ¼ 2.1
Hz) were assigned to Hh and Hf, respectively. Finally, the re-
sonances of Hg, the last signal corresponding to the di-
chlorephenyl group, were observed as a multiplet in the region
7.47–7.43 ppm (J ¼ 2.2/8.1 Hz). This signal was observed to overlap
with Ha.
All the C-H correlations were confirmed by 2D HSQC spectra
(Fig. 6). On the other hand, long-range H-C correlations, deduced
from the analysis of the HMBC spectrum, confirmed the integrity
of the drug skeleton.
Table 1 displays the assignments of the 1H and 13C resonances
of TCZ, as well as the correlations observed in the COSY (Fig. S2),
HMBC (Figs. S3 and S4) and HSQC spectra (Fig. 6). Based on the
analysis described above, several signals previously reported by
Crisóstomo-Lucas et al. [26] were reassigned.
3.2. Identification of TCZ in pharmaceutical dosage forms
With reference to the identification of TCZ in pharmaceutical
dosage forms, they were evaluated employing techniques which
allow identifying TCZ in on-line quality control and continuous
process.
Spectroscopic data on bulk TCZ raw material and commercial
products were obtained and presented in Table 2. TCZ NIR band
corresponding to 1394.5 cm1 was observed at 1387.0 cm1 in them. (B) Pure shift HSQC (blue) and HSQC (red) in the region of 119–139/7.7–6.8 ppm.
Table 1
NMR signal assignments (H and C) of TCZ, employing 1D (1H, 13C and DEPT 135) and 2D (HSQC, HMBC and COSY) experiments.
H C 1H (ppm) J (Hz) 13C (ppm) HSQCa HMBCb COSYc
a 1 7.47–7.43 (1H, m) 137.76 (CH, sp2) þ C2; C3 Hc; Hd
b 2 6.83 (1H, t) 1.1 128.18 (CH, sp2) þ C1; C3 Hc
c 3 7.00 (1H, t) 1.1 119.88 (CH, sp2) þ C1; C2; C4 Ha; Hb; Hd
d 4 4.24–4.19 (2H, m) 50.00 (CH2, sp3) þ C1; C3; C5; C6 Ha; Hc; He
e 5 4.96 (1H, dd) 4.1 76.39 (CH, sp3) þ C4; C6; C7; C11; C12 Hd; Hh; Hi; Hid
6.7
6 134.67 (C, sp2)
7 133.14 (C, sp2)
f 8 7.64 (1H, d) 2.1 128.91 (CH, sp2) þ C6; C7; C9; C10 Hg
9 133.49 (C, sp2)
g 10 7.47–7.43 (1H, m) 2.2 127.78 (CH, sp2) þ C6; C8 Hf; Hh
8.1
h 11 7.36 (1H, d) 8.4 129.29 (CH, sp2) þ C5; C7; C9 Hg
i 12 4.26 (1H, d) 11.9 63.22 (CH2, sp3) þ C5; C13; C14; C16 He; Hj
id 12 4.33 (1H, d) 11.9 63.22 (CH2, sp3) þ C5; C13; C14; C16 Hj
13 126.34(C, sp2)
j 14 6.84 (1H, d) 5.7 127.89 (CH, sp2) þ C12; C13; C15; C16 Hi; Hk
k 15 7.39 (1H, d) 5.7 124.52 (CH, sp2) þ C13; C14; C16 Hj
16 134.73(C, sp2)
a The þ sign indicates that a cross-peak was observed.
b Carbon atoms exhibing cross-peaks with the observed H-atom.
c Hydrogen atoms exhibing cross-peaks with the observed H-atom.
d Hydrogen not equivalent.
Table 2
TCZ spectroscopic data on bulk raw material and commercial products.
Technique TCZ Ovule Nail lacquer
NIR (nm) 1394.5 1392.5 1387.0
1634.0 1634.0 1635.0
1683.0 – 1681.5
1717.5 1726.5 1723.0
1760.5 1761.5 1758.0
1816.5 1816.5 –
2152.5 2153.0 –
2200.0 2200.0 –
2304.5 2311.0 2305.0
FTIR-ATR (cm1) – 721.4 –
626.8 – 626.8
657.7 – 657.7
690.5 – 690.5
733.0 733.0a –
993.3 – 993.3
1336.7 1338.6 1336.7a
1371.4 1375.3 1371.4
1454.3a 1456.5 1454.3a
1464.0 – 1467.8
1562.3 – 1562.3
1587.4 – 1589.3
– 2848.9 2852.7
– 2918.3 2924.1
Raman (cm1) 251.6 251.6 –
265.8 265.8 –
287.0 287.0 –
– – 382.4
450.5 450.5 –
517.4 517.4 –
593.7 593.7 –
– – 634.5
666.3 666.3 –
693.6 693.6 –
833.0 831.0 –
– – 848.9
1068.3 1068.3 –
1088.7 1088.7 –
a Signals corresponding to a shoulder.
Fi
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N.L. Calvo et al. / Journal of Pharmaceutical Analysis 9 (2019) 40–48 45case of the nail lacquer and 1392.5 cm1 in the ovule. In the TCZ
bands at 1683.0, 1717.5, 1760.5, and 2304.5 cm1, similar slides
were observed, where the values of the bands corresponding to
the nail lacquer were closer to the values of TCZ powder, probably
due to the greater concentration of the drug in the product. At the
same time, the ovule presented the same three bands as TCZ at
1816.5, 2153.0 and 2200 cm1.
Several differences were observed when evaluating the FTIR-
ATR spectra of commercial products. The nail lacquer showed a
large number of bands correlated with TCZ (Table 2), whereas the
ovule only presented 7 bands, only 4 of them corresponding to TCZ
at 733 (present in the spectrum as a shoulder), 1338.6, 1375.3 and
1456.5 cm1. Both products showed two bands comprised be-
tween 2840 and 2950 cm1 corresponding to C–H stretches of
alkanes due to excipients of the formulas [38].
Raman spectroscopy could not show TCZ in the nail lacquer,g. 7. DSC thermograms of (A) TCZ, and pharmaceutical dosage forms: (B) ovule
d (C) nail lacquer.
Fig. 8. XRD pattern of (A) nail lacquer, (B) ovule, and (C) TCZ.
N.L. Calvo et al. / Journal of Pharmaceutical Analysis 9 (2019) 40–4846revealing only 3 bands not related to the API, while the ovule
showed 11 bands related to the TCZ with no visible shifts.
When a pharmaceutical formulation is prepared, DSC curves
show changes in the fusion range, area or shape of the peaks, and
disappearance or appearance of thermal events after mixing
components. The obtained curves may indicate interactions or
chemical reactions that must be confirmed by other analytical
techniques [13].
As it is shown in Fig. 7, the DSC thermograms of the different
commercially available formulations were compared with that
generated by TCZ bulk powder. The thermogram of the ovule
formulation presents an endothermic peak centered at 80.4 °C
(enthalpy 7.29 J/g), corresponding to the melting point of TCZ,
which is slightly shifted to the right, maybe due to some interac-
tions with the excipients [13].
It could be estimated that TCZ was partially dissolved in the mix-
ture of excipients or had an increase in the amorphization of the drug
in the ovule because the heat of transition expected for TCZ in DSC
curves [12,13] was reduced compared to the expected theoretical va-
lue (10.17 J/g). Nevertheless, the peak was still distinguishable from the
baseline and displaced to lower temperatures, which in turn indicates
that the drug (or at least part of it) is in the crystalline form [12,13].Fig. 9. TG and DTG curves of (AThe thermal interactions identified by DSC may be related to chemical
interactions between the components of the mixtures or to innocuous
physical interactions [39]. Similar shifting was observed by Verma
et al. [40] when they studied glipizide–excipient compatibility. They
have reported that these minor changes in the melting endotherm of
drug could be due to the mixing of drug and excipient, which lowers
the purity of each component in the mixture and may not necessarily
indicate potential incompatibility. Moreover, Talvani et al. [41] have
developed different carvedilol formulations which showed a decrease
of approximately 10 °C in the drug melting peak evidencing thermal
interactions between the drug and excipient. However, they have also
demonstrated that the observed thermal interactions did not promote
physical or chemical modifications in the drug, verifying the com-
patibility of carvedilol with the used pharmaceutical excipients.
Although the formulation of the nail lacquer has a high ratio of
TCZ (28% (w/v)), the excipients (undecylenic acid and ethyl acet-
ate) allowed a complete dissolution of the drug; therefore, the
melting temperature near 82 °C was not observed on DSC curve. In
order to evaluate the crystalline state of the drug in the pharma-
ceutical formulations, XRD patterns were obtained and analyzed.
The diffraction patterns of the pharmaceutical products are
presented (Fig. 8) and compared with the API. The ovule showed
8 peaks corresponding to the TCZ at 22.33, 27.31, 27.53, 28.39,
29.83, 31.47, 32.17 and 33.13°, confirming that TCZ partially pre-
serves its crystalline structure. Although this sample presents
some degree of drug amorphization, it is clear that a significant
fraction of crystalline drug remains in the ovule, since the main
peaks of original drug crystalline phase can still be observed in the
XRD spectrum [42]. On the other hand, in the diffraction pattern of
the nail lacquer neither peak nor amorphous halo was observed, in
agreement with the results obtained by DSC, confirming that the
API is neither in a crystalline state nor in an amorphous phase.
This could suggest that the drug is dissolved in the formulation.
The commercial products exhibited total mass loss in
two stages (Fig. 9), unlike the TCZ that occurred in only one stage
(Fig. 1B). The greatest loss of mass (92.24%) in the decomposition
of ovule took place between 30 and 360 °C, with two maximum
peaks of decomposition at 304.8 °C related to TCZ in accordance
with the obtained results of TCZ (Fig. 1B) and 321.3 °C. Another
area of mass loss (7.76%) was observed between 360 and 550 °C,
which was attributed to the excipients of the commercial ovule,) nail lacquer and (B) ovule.
N.L. Calvo et al. / Journal of Pharmaceutical Analysis 9 (2019) 40–48 47while in the nail lacquer (Fig. 9A), the decomposition of 48.2%
occurred between 25 and 260 °C with a maximum decomposition
peak at 222.4 °C. Finally, the decomposition of 51.8% of the mass
occurred between 260 and 345 °C, with a maximum registered at
333.1 °C, associated to TCZ, also in accordance with the obtained
results of TCZ (Fig. 1B).4. Conclusions
A complete identification and characterization of TCZ was car-
ried out by using several techniques, presenting NIR, DTG and SEM
images of TCZ for the first time. Additionally, a TCZ structural
elucidation was performed by applying different NMR techniques.
TCZ bulk powder showed a high crystallinity, as observed by
XRD, with a particles size distribution resolved by SEM measure-
ments. TCZ melting point (82.8 °C) and degradation temperature
(297.8 °C) were obtained by DSC and DTG, respectively. An un-
ambiguous elucidation structure of TCZ was obtained by mono-
and two- dimensional 1H and 13C NMR spectral data analysis.
FTIR-ATR, Raman and NIR spectra for the raw material and the
commercial products (ovule and nail lacquer) were obtained and
analyzed tabulating their characteristic bands. It was found that the
best methods for the identification of TCZ in the ovule were thermal
ones (DSC and TG), XRD, NIR and Raman, while NIR and FTIR-ATR
were the most appropriate techniques in the case of the nail lacquer.
Although NMR spectroscopy is a determinant technique to elucidate
the structure, DSC, TG, XRD, FTIR-ATR, NIR and Raman showed to be
effective techniques to be used in online process analysis, as they
require no sample preparation and have been proved to be highly
sensitive to TCZ, even in complex samples.Conflicts of interest
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